
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
LUPN | NSE | INR | Real-time | |
LUPNc1:NS | NSE | INR | Delayed | |
LUPNc2:NS | NSE | INR | Delayed | |
LUPNc3:NS | NSE | INR | Delayed | |
LUPN | BSE | INR | Delayed |
Lupin Limited, together with its subsidiaries, operates as a pharmaceutical company in India, the United States, and internationally. The company operates in two segments: Pharmaceuticals and Others. It engages in the drug discovery, development, production, marketing, and sale of various branded and generic formulations, biosimilars, over-the-counter and specialty drugs, and active pharmaceutical ingredients (APIs). The company also offers formulations for use in the therapeutic areas of anti-tuberculosis, diabetes management, cardiovascular, chronic obstructive pulmonary diseases, asthma, women’s health, and central nervous system areas, as well as pediatrics, gastrointestinal, anti-infective, and nonsteroidal anti-inflammatory drug therapies. In addition, it focuses on various therapeutic spectrum, including rheumatology, oncology, neuroscience, and renal therapies. Further, the company is involved in the provision of diagnostics services, and digital healthcare services; and neuro rehabilition business. It operates through network consists of labs and collection centers. The company was formerly known as Lupin Chemicals Limited and changed its name to Lupin Limited in 2001. Lupin Limited was founded in 1968 and is headquartered in Mumbai, India.
Name | Age | Since | Title |
---|---|---|---|
Manju Deshbandhu Gupta | 77 | 2017 | Non-Executive Chairman of the Board |
Vinita D. Gupta | 55 | 2003 | CEO & Executive Director |
Jean-Luc Belingard | 74 | 2015 | Independent Non-Executive Director |
Punita Kumar Sinha | 63 | 2020 | Independent Director |
Kanwar Bir Singh Anand | 70 | 2020 | Independent Director |
Nilesh Deshbandhu Gupta | - | 2006 | MD & Executive Director |
Alfonso G. Zulueta | 61 | 2024 | Independent Director |
Mark D. McDade | 70 | 2021 | Independent Director |
Jeffrey Kindler | 70 | 2024 | Independent Director |
Punita Lal | 63 | 2025 | Non-Executive Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review